Description:FIELD OF THE INVENTION

[0001] The present invention relates to an automated diabetic medicine preparation device that is designed for the preparation of customized diabetic medicines, by optimizing the formulation of herbal extracts tailored to the health needs of diabetic patients.

BACKGROUND OF THE INVENTION

[0002] For people with diabetes, preparing medication like insulin may be a tricky and stressful task. Traditionally, people have to use syringes or insulin pens, carefully measuring out the right amount of insulin and making sure everything is clean and sterile. This process requires focus and precision, and even small mistakes like giving the wrong dose or not mixing the insulin properly might lead to serious health problems. For many, especially those with limited hand mobility or vision problems, it is difficult to do this safely and consistently. The whole process also be time-consuming and frustrating. Because of these challenges, there’s a clear need for a simpler, more reliable way to prepare diabetic medicine automatically, so people feel confident that they’re getting the right dose without the stress or risk of making errors.

[0003] Traditionally, people used plant-based extracts to help manage diabetes. These methods involved manually grinding herbs, preparing tinctures, and combining various natural remedies to help regulate blood sugar levels. However, these approaches were time-consuming and lacked precision in dosage. So, people also use some machines for preparing diabetic medications, as these machines performs preparation process within less consumption of time and with less human errors. But skilled workers are required for operating such machines efficiently.

[0004] CN213414881U discloses about an invention that includes a diabetes medicine preparation device for pharmacists, which comprises a box body, the top of the box body is hinged with a box cover through a hinge, a plurality of square grids are bolted in the box body, a medicine box is sleeved in the square grids, a medicine outlet is formed in the front surface of the medicine box, and a medicine outlet is formed in the front surface of the medicine box. A week label and a morning, noon and evening label are bonded to the top of the medicine box, a connecting rod is connected to the top of the medicine box in a bolted mode, a ball is connected to the top of the connecting rod in a bolted mode, and the surface of the medicine box is sleeved with a sealing ring; according to the intelligent alarm clock, a pharmacist can place various medicines in the medicine box through cooperation of the medicine outlets according to the order of time according to the doctor's advice, and then the medicine taking time of the intelligent alarm clock is adjusted, so that the pharmacist can conveniently prepare the medicines according to the doctor's advice; the problem that a pharmacist inconveniently dispenses medicine according to medical advice of an existing medicine dispensing device is solved.

[0005] US5886029A discloses about an invention that includes a medicinal composition is provided for treatment of diabetes in a human subject. The medicinal composition of the invention induces a significant reduction in serum glucose due to the regeneration of pancreatic islet cells. A medicinal composition according to the invention necessarily includes a pharmacologically significant quantity of (-) epicatechin augmented with a comparable amount of gymnemic acid. For best results smaller quantities of cinnamomum tamala, syzygium cumini, trigonella foenum graceum, azardichta indica, ficus racemosa, and tinospora cordifolia are also included in the composition. One to two grams of the medicinal composition of the invention are administered to a diabetic human subject three times a day before meals. The unique combination of components in the medicinal composition leads to a regeneration of the pancreas cells which then start producing insulin on their own. Since the composition restores normal pancreatic function, treatment can be discontinued after between about four and twelve months.

[0006] Conventionally, many devices have been developed that are capable of preparing diabetic medicine. However, these devices are incapable of performing different operations from plant drying and grinding to perform extraction and concentration with minimal manual effort, which causes inconsistency and imprecision in the final product. Additionally, these existing devices also fail to ensure that herbal extract preparation is customized to the individual's health condition.

[0007] In order to overcome the aforementioned drawbacks, there exists a need in the art to develop a device that allows users to autonomously prepare a customized herbal extract by performing different operations from plant drying and grinding to perform extraction and concentration, thereby ensuring consistency and precision in the final product. In addition, the developed device also ensure that the herbal extract preparation is customized to the individual's health condition by adjusting the formulation for optimal therapeutic effect.

OBJECTS OF THE INVENTION

[0008] The principal object of the present invention is to overcome the disadvantages of the prior art.

[0009] An object of the present invention is to develop a device that allows users to autonomously prepare a customized herbal extract by performing different operations from plant drying and grinding to extraction and concentration, thereby ensuring consistency and precision in the final product.

[0010] Another object of the present invention is to develop a device that is able to ensure that the herbal extract preparation is customized to the individual's health condition by adjusting the formulation for optimal therapeutic effect.

[0011] Yet another object of the present invention is to develop a device that enable easy access to the final herbal extract by the user, thereby making accessible quite easy and user-friendly for patients with diabetes.

[0012] The foregoing and other objects, features, and advantages of the present invention will become readily apparent upon further review of the following detailed description of the preferred embodiment as illustrated in the accompanying drawings.

SUMMARY OF THE INVENTION

[0013] The present invention relates to an automated diabetic medicine preparation device that is able to provide a means to monitors health of the users and accordingly prepare herbal extracts, for ensuring the precise formulation and dosage based on the user's medical condition.

[0014] According to an embodiment of the present invention, an automated diabetic medicine preparation device comprises of, a housing developed to be positioned on ground surface, installed with a chamber stored with salvia nemorosa plant, a touch interactive display panel is attached with the housing, accessed by a user to input details regarding dietary pattern and health conditions, a motorized air blower integrated inside the chamber to blow a stream of air over aerial parts of plant to dry the plants, a motorized stirrer installed inside the chamber to grind the plant into a fine powder, a motorized iris unit installed on bottom portion of the chamber to open for dispensing the fine powder inside a first container arranged underneath the chamber, where the powder soaks with methanol pre-filled inside the first container for a predefined time before filtering extract to remove solid residues via a filter paper attached to a conduit transferring the extract inside a second container arranged inside the housing, a heating unit embedded within the second container to apply heat to the extract and evaporate solvent present in the extract, leaving behind concentrated extract, a multi-sectioned receptacle is integrated inside the second container, each section stored with different reagents and integrated with an electronic nozzle to dispense the reagents inside the second container, a vibrating unit integrated with the second container to agitate the mixture thoroughly, and a thermostat with a Peltier unit is embedded inside the second container, to maintain optimal temperature inside the second container, ensuring that enzyme activity remains constant and within optimal range for amylase inhibition.

[0015] According to another embodiment of the present invention, the proposed device further comprises of, a color sensor integrated with an artificial intelligence-based imaging unit, both embedded inside the second container detects color change in mixture, indicating presence of bioactive compounds, a pH sensor is integrated within the second container to detect pH value of the concentrated extract, and upon detection of pH level within an optimal range, an electronic valve attached with the second container to open and transfer the concentrated extract towards a pipe lined with the valve, that is further accessed by the user via free-end of the pipe radiating out from front wall of the housing, the microcontroller is integrated with a comprehensive database that stores information related to user’s patient’s medical condition, including type of diabetes, any co-morbidities, and current medications, based on which the microcontroller via a machine learning module integrated with the microcontroller that predicts optimal dosage of salvia nemorosa extract, over the display panel and in case the user is affected by Type 2 diabetes, the microcontroller via a speaker mounted on the housing provides voice alerts to add only roots of salvia nemorosa plants inside the first chamber, and an extract is produced using only roots, helping to improve insulin sensitivity and enhance glucose metabolism.

[0016] While the invention has been described and shown with particular reference to the preferred embodiment, it will be apparent that variations might be possible that would fall within the scope of the present invention.

BRIEF DESCRIPTION OF THE DRAWINGS

[0017] These and other features, aspects, and advantages of the present invention will become better understood with regard to the following description, appended claims, and accompanying drawings where:
Figure 1 illustrates a perspective view of an automated diabetic medicine preparation device.

DETAILED DESCRIPTION OF THE INVENTION

[0018] The following description includes the preferred best mode of one embodiment of the present invention. It will be clear from this description of the invention that the invention is not limited to these illustrated embodiments but that the invention also includes a variety of modifications and embodiments thereto. Therefore, the present description should be seen as illustrative and not limiting. While the invention is susceptible to various modifications and alternative constructions, it should be understood, that there is no intention to limit the invention to the specific form disclosed, but, on the contrary, the invention is to cover all modifications, alternative constructions, and equivalents falling within the spirit and scope of the invention as defined in the claims.

[0019] In any embodiment described herein, the open-ended terms "comprising," "comprises,” and the like (which are synonymous with "including," "having” and "characterized by") may be replaced by the respective partially closed phrases "consisting essentially of," consists essentially of," and the like or the respective closed phrases "consisting of," "consists of, the like.

[0020] As used herein, the singular forms “a,” “an,” and “the” designate both the singular and the plural, unless expressly stated to designate the singular only.

[0021] The present invention relates to an automated diabetic medicine preparation device that enables users to independently create a personalized herbal extract by carrying out various processes, including plant drying, grinding, extraction, and concentration, thereby ensuring both consistency and accuracy in the final product. Additionally, the device ensures that the herbal extract is tailored to the individual’s specific health condition by modifying the formulation for the most effective therapeutic outcome.

[0022] Referring to Figure 1, a perspective view of an automated diabetic medicine preparation device is illustrated, respectively, comprising a housing 101 developed to be positioned on ground surface, installed with a chamber 102, a touch interactive display panel 103 is attached with the housing 101, a motorized air blower 104 integrated inside the chamber 102, a motorized stirrer 105 installed inside the chamber 102, a motorized iris unit 106 installed on bottom portion of the chamber 102, a first container 107 arranged underneath the chamber 102, a conduit 108 transferring the extract inside a second container 109 arranged inside the housing 101, a multi-sectioned receptacle 110 is integrated inside the second container 109, the receptacle 110 is integrated with an electronic nozzle 111, an electronic valve 112 attached with the second container 109, a speaker 113 mounted on the housing 101.

[0023] A housing 101 used herein comprises of a handy and portable cuboidal structure arranged with various components associated with the device, wherein the housing 101 is made up of material that includes but not limited to plastic or metal that ensures that the device is of generous size and is light in weight. The housing 101 is arranged with a chamber 102 which is stored with salvia nemorosa plant.

[0024] The user herein provides touch input command via a touch interactive display panel 103 that is attached with the housing 101. The touch interactive display panel 103 as mentioned herein is typically an LCD (Liquid Crystal Display) screen that presents output in a visible form. The screen is equipped with touch-sensitive technology, allowing the user to interact directly with the display using their fingers. A touch controller IC (Integrated Circuit) is responsible for processing the analog signals generated when the user inputs details regarding dietary pattern and health conditions. A touch controller is typically connected to the microcontroller through various interfaces which may include but are not limited to SPI (Serial Peripheral Interface) or I2C (Inter-Integrated Circuit).

[0025] The microcontroller analyzes the command of the user and accordingly actuates a motorized air blower 104 which is integrated inside the chamber 102. The air blower 104 consists of a motor-driven fan or impeller that generates a high-velocity stream of air. The air blower 104 is typically designed to be compact and energy efficient. The air blower 104 is strategically positioned within the chamber 102 to effectively dry out the aerial parts of plant. The air blower 104 is positioned so that its airflow is directed toward the aerial parts of plant and this is achieved by adjusting the louvers or ducts to focus the airflow. The microcontroller controls the speed and intensity of the air blower 104 and modulates the airflow based on the moisture level of the plants. The microcontroller monitors the drying process and once the plants are dry, the microcontroller automatically turns off the air blower 104 to conserve energy.

[0026] Post drying of the plant, the microcontroller actuates a motorized stirrer 105 installed inside the chamber 102. The motorized stirrer 105 consists of a motor attached to a rotating shaft, which is connected to a stirrer 105 blade. Upon activation, the motor rotates the shaft, causing the stirrer 105 blade to move in a circular motion within the container at a pre-defined speed. This motion ensures uniform grinding of plants, aiding in the consistent grinding of plants into a fine powder, thereby allowing for adjustments based on the requirements of the preparation. As the motor operates, the stirrer 105 blade ensures that plants are grinded into a fine powder.

[0027] A motorized iris unit 106 is installed at the bottom portion of the chamber 102 and is actuated by the microcontroller to control the dispensing of fine powder. Upon activation, the microcontroller sends a signal to the iris unit 106, prompting it to open in a controlled manner. The unit’s iris mechanism consists of interlacing segments that move to form an opening. When opened, the fine powder from the chamber 102 is released into the first container 107 arranged directly underneath.

[0028] The opening size is regulated to ensure precise dispensing of the powder, and the timing of the opening is determined based on the standardized process. Once the required amount of powder is dispensed, the microcontroller signals the iris unit 106 to close, halting the flow of powder. This controlled operation ensures efficient and accurate dispensing while maintaining the integrity of the preparation process.

[0029] The fine powder dispensed into the first container 107 is soaked with methanol pre-filled in the container for a predefined period. During this time, the methanol interacts with the powder to extract its active components. After the soaking period, the extract is filtered to remove solid residues. A filter paper is attached to a conduit 108 that connects the first container 107 to a second container 109. The extract passes through the filter paper, which traps any remaining solid particles. The filtered extract then flows into the second container 109, where it is collected for further processing. The process is controlled by the microcontroller to ensure precise timing and efficiency, ensuring that only the liquid extract is transferred to the second container 109.

[0030] A heating unit embedded within the second container 109 is activated by the microcontroller to apply controlled heat to the extract. This heat application causes the solvent present in the extract to evaporate, leaving behind a concentrated form of the extract. The heating unit is calibrated to ensure that the temperature is maintained at an optimal level, preventing degradation of the active ingredients in the extract. As the solvent evaporates, the concentration of the active compounds increases, resulting in a more potent extract. The evaporation process is monitored by the microcontroller to ensure it is completed efficiently and safely.

[0031] The heating unit used herein is preferably a copper coil that generates heat when an electric current passes through the coil. When an electric current runs through a copper wire the electrons come across the resistive forces of the medium’s material, releasing energy that is expended in the form of heat energy. The copper coil is properly insulated to prevent any heat loss and also direct the generated heat toward the solvent present in the extract. The heating unit begins to generate heat and as the heating element warms up solvent present in the extract, leaving behind concentrated extract.

[0032] A multi-sectioned receptacle 110 is integrated within the second container 109, wherein each section is pre-loaded with different reagents required for further processing of the extract. These reagents are dispensed into the second container 109 through individual electronic nozzle 111, which are controlled by the microcontroller. The microcontroller activates the nozzle 111 at precise intervals to dispense the required amount of reagent into the container, ensuring accurate and consistent formulation.

[0033] Upon activation, the nozzle 111 opens, allowing the specific reagent stored in the receptacle 110 section to flow into the second container 109. The nozzle 111 is designed to dispense a precise amount of the reagent at controlled intervals, ensuring accurate mixing of the extract and reagents. After dispensing, the nozzle 111 closes automatically to prevent further release of the reagent. This process is repeated as needed, with the microcontroller continuously regulating the timing and amount of reagent dispensed for optimal results.

[0034] A vibrating unit is integrated with the second container 109 and is activated by the microcontroller. Upon activation, the unit generates vibrations at a controlled frequency and intensity, causing the mixture inside the second container 109 to agitate. This agitation ensures thorough mixing of the extract and reagents, enhancing the extraction process.

[0035] The vibrating unit is activated by the microcontroller, which sends a signal to initiate the motor. Once activated, the motor generates oscillatory motion, causing the entire unit to vibrate. This vibration is transmitted to the second container 109, agitating the mixture inside. The vibrations break up any solid residues, ensuring even distribution of the reagents within the extract. The intensity and frequency of the vibrations are controlled by the microcontroller, allowing precise agitation for optimal extraction. The movement ensures that the contents are thoroughly mixed, aiding in efficient processing of the mixture.

[0036] A Peltier unit embedded inside the second container 109 is controlled by the microcontroller to maintain a consistent temperature. Prior actuation of the Peltier unit, the microcontroller determines the temperature of the environment by a thermostat. The thermostat works by monitoring the temperature of its environment through a built-in temperature sensor. The temperature sensor comprises crucial components such as an infrared sensor, an optical arrangement, and a detector. It functions on the principle of detecting infrared radiation emitted by the surrounding. When the temperature exceeds absolute zero, it emits infrared radiation. The sensor captures this radiation using its optical arrangement, directing it onto a detector. Common detectors, like thermopiles or pyroelectric sensors, then convert the received infrared energy into an electrical signal. This signal undergoes processing by electronic components, translating it into a temperature reading of the surroundings.

[0037] The thermostat continuously monitors the temperature and adjusts the temperature accordingly to maintain a consistent, comfortable temperature within the specified range. Upon receiving signals from the microcontroller, the Peltier unit gets actuated and absorbs heat to regulate the temperature within the container 109. This dynamic temperature control ensures that the environment remains within an optimal range for enzyme activity, particularly for amylase inhibition. By continuously monitoring and adjusting the temperature, the Peltier unit helps to maintain the conditions necessary for effective extraction and processing, preventing temperature fluctuations that could interfere with the desired enzymatic activity.

[0038] A color sensor, integrated with an artificial intelligence-based imaging unit embedded inside the second container 109, is configured to detect changes in the color of the mixture within the container. The color sensor detects the color of the mixture inside the second container 109 by emitting light and measuring the reflected light from the mixture. The sensor analyzes the light's intensity and wavelength to determine any color changes. These changes indicate the presence of bioactive compounds. The sensor then converts this data into digital signals, which are sent to the integrated artificial intelligence-based imaging unit. The unit processes the data, comparing the detected color against predefined color profiles, allowing it to determine the composition and presence of bioactive compounds in the mixture.

[0039] A pH sensor, integrated within the second container 109, continuously monitors the pH level of the concentrated extract. The sensor operates by emitting a voltage in response to the hydrogen ion concentration in the extract. The microcontroller receives the pH data from the sensor, and, the microcontroller monitors the pH level of the concentrated extract. These actions ensure that the extract is within the desired chemical conditions, confirming the successful preparation of the extract for its intended use.

[0040] In the event that the pH of the solution is lowered beyond the optimal range for the enzyme, a corresponding reduction in enzyme activity will occur. Enzymes, such as α-amylase, exhibit optimal functionality within a specific pH range, and deviations from this range, either through excessive acidity (low pH) or alkalinity (high pH), result in a decrease in their catalytic efficiency. As the determined activity of α-amylase remains elevated, indicating that the inhibitory effect of the plant extract is insufficient, the system then initiates an increase in the concentration of the plant extract. This adjustment aims to enhance the inhibition process, ensuring that the α-amylase activity is appropriately reduced to the desired level.

[0041] Upon the detection of the pH level falling within the predefined optimal range, the microcontroller activates an electronic valve 112 integrated with the second container 109. The actuation of this valve 112 enables the transfer of the concentrated extract from the second container 109 to a pipe connected to the valve 112. The pipe, lined with the valve 112, directs the extract toward the free end of the pipe, which extends outward from the front wall of the housing 101. This design allows the user to easily access the concentrated extract for further use by directing it from the pipe's free end.

[0042] The microcontroller is integrated with a comprehensive database containing detailed information related to the user's medical condition, including the type of diabetes, any co-morbidities, and current medications. Based on this data, the microcontroller, in conjunction with an integrated machine learning module, processes the information to predict the optimal dosage of salvia nemorosa extract. This predicted dosage is then displayed on the display panel 103, ensuring the user receives a personalized and accurate recommendation for their treatment. The machine learning module continuously refines its predictions based on new data, improving accuracy over time and ensuring optimal therapeutic efficacy.

[0043] In the event that the user is diagnosed with Type 2 diabetes, the microcontroller, through a speaker 113 mounted on the housing 101, delivers voice alerts instructing the user to add only the roots of salvia nemorosa plants into the first chamber 102. The device ensures that the extract is produced solely from the roots, which are known to aid in improving insulin sensitivity and enhancing glucose metabolism. These voice prompts are generated to guide the user in following the specific preparation instructions for optimal therapeutic benefits related to managing Type 2 diabetes, ensuring precision in the treatment formulation.

[0044] The speaker 113 consists of audio information, which is in the form of recorded voice, synthesized voice, or other sounds, generated or stored as digital data. The digital audio data is converted into analog electrical signals. Further the analog signal is amplified by an amplifier and the amplified audio signal is then sent to the speaker 113. The core of the speaker 113 is an electromagnet attached to a flexible cone. These sound waves travel through the air as pressure waves and are picked by the user’s ear. The speaker 113 is connected to the microcontroller and when detected that the user is affected by Type 2 diabetes, the microcontroller activates the speaker 113 to provide alert to add only roots of salvia nemorosa plants inside the first chamber 102, and an extract is produced using only roots, helping to improve insulin sensitivity and enhance glucose metabolism.

[0045] Moreover, a battery is associated with the device for powering up electrical and electronically operated components associated with the device and supplying a voltage to the components. The battery used herein is preferably a Lithium-ion battery which is a rechargeable unit that demands power supply after getting drained. The battery stores the electric current derived from an external source in the form of chemical energy, which when required by the electronic component of the device, derives the required power from the battery for proper functioning of the device.

[0046] The present invention works in the best manner, where the housing 101 developed to be positioned on ground surface. Then the chamber 102 stored with salvia nemorosa plant. Now the touch interactive display panel 103 is attached with the housing 101, accessed by the user to input details regarding dietary pattern and health conditions. Upon receiving the user’s commands the motorized air blower 104 blow the stream of air over aerial parts of plant to dry the plants. Post drying of the plant the motorized stirrer 105 grinds the plant into the fine powder. Thereafter the motorized iris unit 106 open for dispensing the fine powder inside the first container 107 arranged underneath the chamber 102. Where the powder soaks with methanol pre-filled inside the first container 107 for the predefined time before filtering extract to remove solid residues via the filter paper attached to the conduit 108 transferring the extract inside the second container 109 arranged inside the housing 101. Then the heating unit apply heat to the extract and evaporate solvent present in the extract, leaving behind concentrated extract. Now the multi-sectioned receptacle 110 stored with different reagents and integrated with the electronic nozzle 111 that dispense the reagents inside the second container 109. Synchronously, the vibrating unit agitate the mixture thoroughly. Also, the Peltier unit maintain optimal temperature inside the second container 109, for ensuring that enzyme activity remains constant and within optimal range for amylase inhibition.

[0047] In continuation, then the color sensor detects color change in mixture, indicating presence of bioactive compounds. Afterwards the pH sensor detects pH value of the concentrated extract. Upon detection of pH level within the optimal range the electronic valve 112 attached with the second container 109 to open and transfer the concentrated extract towards the pipe lined with the valve 112, that is further accessed by the user via free-end of the pipe radiating out from front wall of the housing 101. Further the microcontroller is integrated with the comprehensive database that stores information related to user’s patient’s medical condition, including type of diabetes, any co-morbidities, and current medications. Based on which the microcontroller via the machine learning module integrated with the microcontroller that predicts optimal dosage of salvia nemorosa extract, over the display panel 103. Moreover, in case the user is affected by Type 2 diabetes, the microcontroller via the speaker 113 alerts to add only roots of salvia nemorosa plants inside the first chamber 102, and the extract is produced using only roots, helping to improve insulin sensitivity and enhance glucose metabolism.

[0048] Although the field of the invention has been described herein with limited reference to specific embodiments, this description is not meant to be construed in a limiting sense. Various modifications of the disclosed embodiments, as well as alternate embodiments of the invention, will become apparent to persons skilled in the art upon reference to the description of the invention. , Claims:1) An automated diabetic medicine preparation device, comprising:

i) a housing 101 developed to be positioned on a ground surface, installed with a chamber 102 stored with salvia nemorosa plant, wherein a touch interactive display panel 103 is attached with said housing 101, accessed by a user to input details regarding dietary pattern and health conditions;

ii) a microcontroller linked with said panel 103 which on receiving said user’s commands activates a motorized air blower 104 integrated inside said chamber 102 to blow a stream of air over aerial parts of plant to dry said plants, wherein post drying of said plant, said microcontroller actuates a motorized stirrer 105 installed inside said chamber 102 to grind said plant into a fine powder;

iii) a motorized iris unit 106 installed on bottom portion of said chamber 102 that is actuated by said microcontroller to open for dispensing said fine powder inside a first container 107 that is arranged underneath said chamber 102, where said powder soaks with methanol pre-filled inside said first container 107 for a predefined period of time before filtering extract to remove solid residues via a filter paper attached in the path of a conduit 108 transferring said extract inside a second container 109 arranged inside said housing 101;

iv) a heating unit embedded within said second container 109 to apply heat to said extract and evaporate solvent present in said extract, leaving behind concentrated extract, wherein a multi-sectioned receptacle 110 is integrated inside said second container 109, each section stored with different reagents and integrated with an electronic nozzle 111 that is actuated by said microcontroller to dispense said reagents inside said second container 109, followed by actuation of a vibrating unit integrated with said second container 109 to agitate said mixture thoroughly;

v) a color sensor integrated with an artificial intelligence-based imaging unit, both embedded inside said second container 109 detects color change in mixture, indicating presence of bioactive compounds; and

vi) a pH sensor integrated within said second container 109 to detect pH value of said concentrated extract, wherein upon detection of pH level within an optimal range, said microcontroller actuates an electronic valve 112 attached with said second container 109 to open and transfer said concentrated extract towards a pipe line connected with said valve 112, that is further accessed by said user via free-end of said pipe radiating out from front wall of said housing 101.

2) The device as claimed in claim 1, wherein a thermostat with a Peltier unit is embedded inside said second container 109, dynamically regulated by said microcontroller to maintain optimal temperature inside said second container 109, ensuring that enzyme activity remains constant and within optimal range for amylase inhibition.

3) The device as claimed in claim 1, wherein said microcontroller is integrated with a comprehensive database that stores information related to user’s patient’s medical condition, including type of diabetes, any co-morbidities, and current medications, based on which said microcontroller via a machine learning module integrated with said microcontroller predicts optimal dosage of salvia nemorosa extract, over said display panel 103.

4) The device as claimed in claim 1, wherein in case said user is affected by Type 2 diabetes, said microcontroller via a speaker 113 mounted on said housing 101 provides voice alerts to add only roots of salvia nemorosa plants inside said first chamber 102, and an extract is produced using only two roots, helping to improve insulin sensitivity and enhance glucose metabolism.